Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

92.34USD
11 Dec 2018
Change (% chg)

-- (--)
Prev Close
$92.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
413,841
52-wk High
$106.69
52-wk Low
$75.84

Chart for

About

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products... (more)

Overall

Beta: 1.80
Market Cap(Mil.): $16,617.19
Shares Outstanding(Mil.): 175.27
Dividend: --
Yield (%): --

Financials

  BMRN.OQ Industry Sector
P/E (TTM): -- 31.13 33.63
EPS (TTM): -1.02 -- --
ROI: -5.48 15.55 15.02
ROE: -7.41 16.92 16.60

BioMarin sets stage early for hemophilia cure off-Broadway

(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six people in clinical trials)

22 Nov 2018

Earnings vs. Estimates